Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities
Clinical evidence indicates that injectable options can help patients lose 15% to 20% of their total body weight over a sustained period, while oral forms typically yield a more modest 5% to 10% reduction
How we protect muscle and strength in our practice In our practice, patients who stay strong and energetic through weight loss are almost always doing a few specific things, and we coach toward them from day one: Eat enough protein Protein is the single biggest lever
If coverage is denied, they help explore alternatives like patient assistance programs or cash-pay compounded meds (not FDA approved and limited access in some states)
There are two major issues with this whole situation, and some critical questions need to be answered
Making the most of probiotics